NINGEN INDEXSee Companies Through People.
EN日本語

Human Capital Disclosure Assessment

ONO PHARMACEUTICAL CO.,LTD.

4528TSE Prime · Listed · Checked 2026-10-26Pharmaceutical2026-03-31

Assessment Scores

Company coverage reference date: 2026-08-31

Overall Score

53.0 / 100
Scores by Assessment Area and Component
Disclosure Governance15.5 / 20
Human Intangible Assets30.0 / 40
Technical Knowledge8.75 / 10
Skills7.5 / 15
Motivation13.75 / 15
Human Capital Investment Flow7.5 / 40

Overall Disclosure Profile

ONO PHARMACEUTICAL CO.,LTD. distinguishes specialist personnel responsible for growth strategy from personnel supporting management and digitalization across departments, and specifies the required capabilities and development goals. Of its 1,056 digital personnel in FY2025, 270 could plan, manage, and execute DX projects. In addition to training, overseas assignments, and subsidies for self-directed learning, it provides opportunities to broaden experience through internal job postings and concurrent positions.

In FY2025, the average post-training behavioral change rate was 87% based on supervisor assessments. The engagement index, indicating willingness to contribute proactively to organizational success, was 72, up 2 points year on year. However, the specific criteria for determining behavioral change, the breakdown of capabilities acquired through training, and contributions to business outcomes are not sufficiently presented. The cumulative number of employees holding concurrent internal positions is disclosed as 95. Childcare leave and wage differences are presented for the parent company, while explanations of the same indicators for subsidiaries covered by the filing are insufficient.

Scores by Assessment Item

Scores assess disclosures in the Annual Securities Report. A score of zero does not mean that an initiative is not implemented or that employees lack capability.

Scores for each of the 16 assessment items
Disclosure Governance
G1Disclosure of Basic Quantitative Information3 / 5
G2Governance and Risk Management3.75 / 5
G3Human Capital Strategy and Basic Policy5.0 / 5
G4Clarity of Indicators, Targets, and Explanations3.75 / 5
Human Intangible Assets
Technical Knowledge
T1Technical Knowledge Base5.0 / 5
T2Acquisition and Accumulation of Technical Knowledge3.75 / 5
Skills
S1Alignment between Technical Knowledge and Practical Work3.75 / 5
S2Volume of Use and Application0.0 / 5
S3Continued Use and Expansion3.75 / 5
Motivation
M1Mechanisms Supporting Motivation5.0 / 5
M2Track Record of Operation5.0 / 5
M3Employee State and Change3.75 / 5
Human Capital Investment Flow
F1Logic from Investment to Outcomes5.0 / 10
F2Magnitude of Outcomes0.0 / 10
F3Calculation Basis and Use in Planning0.0 / 10
F4Verification of the Relationship2.5 / 10

Assessment History

2025-04-01 – 2026-03-31 · Latest recorded assessment

No earlier assessments are recorded. Comparability across periods has not been confirmed.

Sources & Assessment Scope

Current Company Information

Current name source · Listing status source

Filing Information

Assessment Scope & Disclaimer

This assessment is based solely on information disclosed in the company's Japanese-language Annual Securities Report filed through EDINET.

It does not assess the human capital initiatives a company actually implements or the company's human capital capabilities themselves.

Items for which no disclosure was identified in the Annual Securities Report receive no points, regardless of whether the company actually implements the relevant initiatives.

This English-language assessment is a translation of the original Japanese assessment and is provided for convenience. In the event of any discrepancy, the Japanese assessment prevails.